Attri Joginder Pal, Sandhu Gagandeep Kaur, Khichy Sudhir, Singh Harsimrat, Singh Kulwinder, Sharan Radhe
Department of Anaesthesia, Government Medical College, Amritsar, Punjab, India.
Department of Surgery, Government Medical College, Amritsar, Punjab, India.
Anesth Essays Res. 2015 Jan-Apr;9(1):72-8. doi: 10.4103/0259-1162.150681.
Flupirtine is a centrally-acting, nonopioid analgesic that interacts with N-methyl-D-aspartate receptors.
The present study was designed to compare analgesic efficacy and adverse effects of orally administered flupirtine and diclofenac sodium for postoperative pain relief.
In a prospective, randomized double-blind study, 100 patients of American Society of Anesthesiologist grade I and II in the age group of 18-65 years of either sex undergoing elective abdominal surgeries were included after taking informed consent.
The present study started after 12 h of surgery and patients were randomly divided into two groups of 50 each. For postoperative analgesia, group A received flupirtine 100 mg orally and group B received diclofenac sodium 50 mg orally and study drugs were repeated every 6 hourly for 5 days postoperatively. Vital parameters and visual analogue scale (VAS) scores for pain were recorded at 0, 1, 2, 4, 6, 8, 12, 16 and 24 h, and adverse effects were noted for 48 h of the study period.
Data were compiled and analyzed statistically using Chi-square test and two-tailed Student's t-test.
Visual analogue scores decreased more rapidly in diclofenac group during 1(st) h, hence there was rapid onset of analgesia in this group as compared to flupirtine group but later on VAS was comparable in both groups at all measured intervals (P > 0.05). Patients in diclofenac group experienced significantly more heartburn (P = 0.00), impaired taste sensation (P < 0.001) and dizziness (P = 0.004) as compared to flupirtine group.
Oral flupirtine and diclofenac sodium were equally effective for postoperative analgesia. There was faster onset of analgesia with diclofenac sodium, but flupirtine was better tolerated by the patients because of its minimal adverse effects.
氟吡汀是一种作用于中枢的非阿片类镇痛药,可与N - 甲基 - D - 天冬氨酸受体相互作用。
本研究旨在比较口服氟吡汀和双氯芬酸钠用于术后镇痛的疗效及不良反应。
在一项前瞻性、随机双盲研究中,纳入100例年龄在18 - 65岁、美国麻醉医师协会分级为I级和II级、接受择期腹部手术的患者,患者均签署知情同意书。
本研究在术后12小时开始,患者被随机分为两组,每组50例。术后镇痛时,A组口服氟吡汀100mg,B组口服双氯芬酸钠50mg,术后5天每6小时重复给药一次。在0、1、2、4、6、8、12、16和24小时记录生命体征参数及疼痛视觉模拟量表(VAS)评分,并在研究期间48小时内记录不良反应。
数据采用卡方检验和双尾学生t检验进行统计汇编和分析。
双氯芬酸组在第1小时内视觉模拟评分下降更快,因此与氟吡汀组相比,该组镇痛起效更快,但随后在所有测量时间点两组的VAS评分相当(P > 0.05)。与氟吡汀组相比,双氯芬酸组患者出现烧心(P = 0.00)、味觉障碍(P < 0.001)和头晕(P = 0.004)的情况明显更多。
口服氟吡汀和双氯芬酸钠在术后镇痛方面同样有效。双氯芬酸钠镇痛起效更快,但氟吡汀不良反应极小,患者耐受性更好。